Eilean Therapeutics, LLC

Insider Reports History

Location
8 The Green Suite 8183, Dover, DE
Signature
/s/ Iain Dukes, CEO of Eilean Therapeutics, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eilean Therapeutics, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Venetian-1 Acquisition Corp. 10%+ Owner Common Stock 14.4M $57.7M $4.00 Nov 1, 2024 Direct

Insider Reports Filed by Eilean Therapeutics, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NONE Lomond Therapeutics Holdings, Inc. Nov 1, 2024 0 $0 3 Nov 5, 2024 10%+ Owner